Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ambica, Baru"'
Autor:
R. S. Gupta, Ambica Baru, Swati Sharma, Saumyabrata Mazumdar, Nupur Mehrotra Arora, Sameena Khan, Prabuddha Kumar Kundu, Biswa Pratim Das Purakayastha
Publikováno v:
ASSAY and Drug Development Technologies. 19:361-372
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of act
Autor:
Ambica Baru, Saumyabrata Mazumder, Prabuddha Kundu, Swati Sharma, Biswa Pratim Purakayastha, Sameena Khan, Reeshu Gupta, Nupur Arora
Publikováno v:
Oncology reports. 49(1)
Cancer can be fatal if it is not treated in a timely manner; therefore, there is a high demand for more specific oncology drugs. Unfortunately, drugs showing positive responses on a two‑dimensional (2D) culture platform do not often show the same e
Autor:
Ambica Baru, Saumyabrata Mazumder, Prabuddha Kundu, Swati Sharma, Biswa Das Purkayastha, Sameena Khan, Reeshu Gupta, Nupur Mehrotra Arora
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 23(2)
The formation of three-dimensional spheroid tumor model using the scaffold-based platforms has been demonstrated over many years now. 3D tumor models are generated mainly in non-scalable culture systems, using synthetic and biological scaffolds. Many
Autor:
Ambica, Baru, Swati, Sharma, Biswa Pratim Das, Purakayastha, Sameena, Khan, Saumyabrata, Mazumdar, Reeshu, Gupta, Prabuddha K, Kundu, Nupur Mehrotra, Arora
Publikováno v:
Assay and drug development technologies. 19(6)
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of act
Autor:
Sameena Khan, Nupur Mehrotra Arora, Ambica Baru, Prabuddha Kumar Kundu, Saumyabrata Mazumdar, Swati Sharma, Biswa Pratim Das Purakayastha, R. S. Gupta
The formation of three-dimensional spheroid tumor model using the scaffold-based platforms has been demonstrated over many years now. 3D tumor models are generated mainly in non-scalable culture systems, using synthetic and biological scaffolds. Many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4b11faf7317b1f2d63ec8b4525617d
https://doi.org/10.1101/2020.12.21.423825
https://doi.org/10.1101/2020.12.21.423825
Autor:
R. S. Gupta, Prabuddha Kumar Kundu, Nupur Mehrotra Arora, Sameena Khan, Purkayastha Bpd, Saumyabrata Mazumder, Swati Sharma, Ambica Baru
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ~7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O is the problem of developing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba4341dcb7fc75a2c425b19194d7585e
https://doi.org/10.1101/2020.11.05.369751
https://doi.org/10.1101/2020.11.05.369751
Publikováno v:
Biological Systems: Open Access.
Background: Methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl) carbamate [Fenbendazole, FZ] is an anthelmintic drug which acts by selectively binding to β tubulin of nematodes, inhibiting the tubulin polymerization and blocking microtubule dependent g